Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Astellas Pharma key operating metrics including Phase I Trials Products (Regeneration), environmental, and social and governance score (ESG).

Phase I Trials Products (Regeneration)

1

Oct, 2020

Phase I Trials Products (Antigen Specific Immunomodulation)

2

FY, 2020

Phase II Trials Products (Mitochondria)

2

Oct, 2020

Operating Metrics

MetricsFY, 2020
Phase I Trials Products (Regeneration)1
Phase I Trials Products (Antigen Specific Immunomodulation)2
Phase II Trials Products (Mitochondria)1
Phase I Trials Products (Mitochondria)1
Phase II Trials Products (Genetic Regulation)1
Phase I Trials Products (Genetic Regulation)1
Phase I Trials Products (Immuno-Oncology)5
Phase III Trials Products (Oncology)4
Phase II Trials Products (Oncology)1
Phase I Trials Products (Oncology)1
Phase III Trials Products (Immunology)1
Phase II Trials Products (Immunology)1
Phase I Trials Products (Immunology)1
Phase III Trials Products (Other)1
Phase II Trials Products (Other)2
Phase I Trials Products (Other)1
Phase III Trials Products (Urology and Nephrology)5
Phase II Trials Products (Urology and Nephrology)2
Phase II Trials Products (Regeneration)2

Environmental, Social and Governance (ESG)

Overall

60-79 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal
Learn more

Source:CSRHub

Footer menu